D'Souza Deepak Cyril, Cortes-Briones Jose A, Ranganathan Mohini, Thurnauer Halle, Creatura Gina, Surti Toral, Planeta Beata, Neumeister Alexander, Pittman Brian, Normandin Marc, Kapinos Michael, Ropchan Jim, Huang Yiyun, Carson Richard E, Skosnik Patrick D
Schizophrenia and Neuropharmacology Research Group, VA Connecticut Healthcare System, West Haven, CT, USA; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Department of Radiology, Yale University School of Medicine, New Haven, CT, USA.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):60-67. doi: 10.1016/j.bpsc.2015.09.008.
The widespread use of cannabis, the increasing legalization of "medical" cannabis, the increasing potency of cannabis and the growing recreational use of synthetic cannabinoid 1 receptor (CB1R) full agonists underscores the importance of elucidating the effects of cannabinoids on the CB1R system. Exposure to cannabinoids is known to result in CB1R downregulation. However, the precise time course of changes in CB1R availability in cannabis dependent subjects (CDs) following short and intermediate term abstinence has not been determined.
Using High Resolution Research Tomography (HRRT) and [C]OMAR, CB1R availability as indexed by the volume of distribution () [C]OMAR was measured in male CDs (n=11) and matched healthy controls (HCs) (n=19). CDs were scanned at baseline (while they were neither intoxicated nor in withdrawal), and after 2 days and 28 days of monitored abstinence. HCs were scanned at baseline and a subset (n=4) was rescanned 28 days later.
Compared to HCs, [C]OMAR was 15% lower in CDs (effect size Cohen's d=-1.11) at baseline in almost all brain regions. However, these group differences in CB1R availability were no longer evident after just 2 days of monitored abstinence from cannabis. There was a robust negative correlation between CB1R availability and withdrawal symptoms after 2 days of abstinence. Finally, there were no significant group differences in CB1R availability in CDs after 28 days of abstinence.
Cannabis dependence is associated with CB1R downregulation, which begins to reverse surprisingly rapidly upon termination of cannabis use and may continue to increase over time.
大麻的广泛使用、“医用”大麻日益合法化、大麻效力增强以及合成大麻素1受体(CB1R)完全激动剂的娱乐性使用增加,凸显了阐明大麻素对CB1R系统影响的重要性。已知接触大麻素会导致CB1R下调。然而,大麻依赖者(CDs)在短期和中期禁欲后CB1R可用性变化的精确时间进程尚未确定。
使用高分辨率研究断层扫描(HRRT)和[C]OMAR,在男性CDs(n = 11)和匹配的健康对照者(HCs,n = 19)中测量以分布容积()[C]OMAR为指标的CB1R可用性。CDs在基线时(既未中毒也未戒断时)以及在监测禁欲2天和28天后进行扫描。HCs在基线时进行扫描,其中一个子集(n = 4)在28天后再次扫描。
与HCs相比,几乎所有脑区中CDs在基线时的[C]OMAR降低了15%(效应大小Cohen's d = -1.11)。然而,在监测禁欲大麻仅2天后,这些CB1R可用性的组间差异不再明显。禁欲2天后,CB1R可用性与戒断症状之间存在强烈的负相关。最后,禁欲28天后CDs的CB1R可用性在组间无显著差异。
大麻依赖与CB1R下调有关,在停止使用大麻后,CB1R下调开始惊人地迅速逆转,并且可能会随着时间的推移继续增加。